FULGENT GENETICS, INC. Income Taxes Paid
FULGENT GENETICS, INC. (FLGT) reported Income Taxes Paid of $32.94 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-02-27
- FULGENT GENETICS, INC. income taxes paid for the quarter ending 2025-09-30 was $133.00K, a 99.46% decline year-over-year.
- FULGENT GENETICS, INC. income taxes paid for the quarter ending 2025-06-30 was $32.75M, a 5394.80% increase year-over-year.
- FULGENT GENETICS, INC. income taxes paid for the quarter ending 2025-03-31 was $54.00K, a 95.87% decline year-over-year.
- FULGENT GENETICS, INC. income taxes paid for the quarter ending 2024-12-31 was $946.00K, a 68.03% increase year-over-year.
- FULGENT GENETICS, INC. income taxes paid for fiscal 2024 was $27.59M, a 746.00% increase from fiscal 2023.
- FULGENT GENETICS, INC. income taxes paid for fiscal 2023 was $3.26M, a 94.20% decline from fiscal 2022.
- FULGENT GENETICS, INC. income taxes paid for fiscal 2022 was $56.19M, a 76.30% decline from fiscal 2021.
- FULGENT GENETICS, INC. income taxes paid for fiscal 2021 was $237.07M, a 1050.15% increase from fiscal 2020.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2025-09-30 | $133.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $32.88M derived: sum of 2 quarters · filed 2025-11-07 | $32.94M 10-Q · filed 2025-11-07 | $33.88M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | $32.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $32.80M 10-Q · filed 2025-08-01 | $33.75M derived: sum of 3 quarters · filed 2026-02-27 | $58.49M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | $54.00K 10-Q · filed 2025-05-02 | $1.00M derived: sum of 2 quarters · filed 2026-02-27 | $25.74M derived: sum of 3 quarters · filed 2026-02-27 | $26.34M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | $946.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $25.68M derived: sum of 2 quarters · filed 2026-02-27 | $26.28M derived: sum of 3 quarters · filed 2026-02-27 | $27.59M 10-K · filed 2026-02-27 |
| 2024-09-30 | $24.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $25.34M derived: sum of 2 quarters · filed 2025-11-07 | $26.64M 10-Q · filed 2025-11-07 | $27.20M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $596.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $1.90M 10-Q · filed 2025-08-01 | $2.47M derived: sum of 3 quarters · filed 2026-02-27 | $2.53M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $1.31M 10-Q · filed 2025-05-02 | $1.87M derived: sum of 2 quarters · filed 2026-02-27 | $1.93M derived: sum of 3 quarters · filed 2026-02-27 | $2.89M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $563.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $625.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.58M derived: sum of 3 quarters · filed 2026-02-27 | $3.26M 10-K · filed 2026-02-27 |
| 2023-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.02M derived: sum of 2 quarters · filed 2024-11-08 | $2.70M 10-Q · filed 2024-11-08 | $2.71M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $956.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $2.64M 10-Q · filed 2024-08-02 | $2.65M derived: sum of 3 quarters · filed 2025-02-28 | $3.85M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $1.68M 10-Q · filed 2024-05-03 | $1.69M derived: sum of 2 quarters · filed 2025-02-28 | $2.89M derived: sum of 3 quarters · filed 2025-02-28 | $57.44M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.21M derived: sum of 2 quarters · filed 2025-02-28 | $55.76M derived: sum of 3 quarters · filed 2025-02-28 | $56.19M 10-K · filed 2025-02-28 |
| 2022-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $55.75M derived: sum of 2 quarters · filed 2023-11-03 | $56.18M 10-Q · filed 2023-11-03 | $123.71M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $54.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $54.98M 10-Q · filed 2023-08-04 | $122.51M derived: sum of 3 quarters · filed 2024-02-28 | $172.07M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $435.00K 10-Q · filed 2023-05-05 | $67.96M derived: sum of 2 quarters · filed 2024-02-28 | $117.52M derived: sum of 3 quarters · filed 2024-02-28 | $237.47M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $67.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $117.09M derived: sum of 2 quarters · filed 2024-02-28 | $237.04M derived: sum of 3 quarters · filed 2024-02-28 | $237.07M 10-K · filed 2024-02-28 |
| 2021-09-30 | $49.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $169.51M derived: sum of 2 quarters · filed 2022-11-07 | $169.54M 10-Q · filed 2022-11-07 | $190.12M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $119.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $119.98M 10-Q · filed 2022-08-04 | $140.56M derived: sum of 3 quarters · filed 2023-02-28 | $140.56M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $33.00K 10-Q · filed 2022-05-05 | $20.62M derived: sum of 2 quarters · filed 2023-02-28 | $20.62M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | $20.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $20.58M derived: sum of 2 quarters · filed 2023-02-28 | $20.61M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $28.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $28.00K 10-Q · filed 2021-08-10 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $20.00K 10-K · filed 2022-02-28 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $20.00K 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $20.00K 10-Q · filed 2020-08-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $1.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $1.00K 10-Q · filed 2019-08-12 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $1.00K derived: sum of 2 quarters · filed 2019-03-22 | $757.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $757.00K 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | $756.00K 10-Q · filed 2018-08-13 | |||
| 2016-12-31 | $550.00K 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |